WO2005049066A3 - Proteine impliquee dans le cancer du poumon - Google Patents
Proteine impliquee dans le cancer du poumon Download PDFInfo
- Publication number
- WO2005049066A3 WO2005049066A3 PCT/GB2004/004847 GB2004004847W WO2005049066A3 WO 2005049066 A3 WO2005049066 A3 WO 2005049066A3 GB 2004004847 W GB2004004847 W GB 2004004847W WO 2005049066 A3 WO2005049066 A3 WO 2005049066A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- dudulin2
- prophylaxis
- treatment
- lung cancer
- modulate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57423—Specifically defined cancers of lung
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Organic Chemistry (AREA)
- Cell Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0326834.9 | 2003-11-18 | ||
GBGB0326834.9A GB0326834D0 (en) | 2003-11-18 | 2003-11-18 | A protein involved in lung cancer |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005049066A2 WO2005049066A2 (fr) | 2005-06-02 |
WO2005049066A3 true WO2005049066A3 (fr) | 2005-07-14 |
Family
ID=29764007
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2004/004847 WO2005049066A2 (fr) | 2003-11-18 | 2004-11-16 | Proteine impliquee dans le cancer du poumon |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB0326834D0 (fr) |
WO (1) | WO2005049066A2 (fr) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001053454A2 (fr) * | 2000-01-21 | 2001-07-26 | Hyseq, Inc. | Procedes et elements ayant trait a des polypeptides et des polynucleotides de type recepteurs couples a une proteine g |
WO2001072962A2 (fr) * | 2000-03-24 | 2001-10-04 | Fahri Saatcioglu | Molecules d'acide nucleique specifiques de la prostate ou des testicules, polypeptides, techniques de diagnostic, et traitement therapeutique |
-
2003
- 2003-11-18 GB GBGB0326834.9A patent/GB0326834D0/en not_active Ceased
-
2004
- 2004-11-16 WO PCT/GB2004/004847 patent/WO2005049066A2/fr active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001053454A2 (fr) * | 2000-01-21 | 2001-07-26 | Hyseq, Inc. | Procedes et elements ayant trait a des polypeptides et des polynucleotides de type recepteurs couples a une proteine g |
WO2001072962A2 (fr) * | 2000-03-24 | 2001-10-04 | Fahri Saatcioglu | Molecules d'acide nucleique specifiques de la prostate ou des testicules, polypeptides, techniques de diagnostic, et traitement therapeutique |
Also Published As
Publication number | Publication date |
---|---|
GB0326834D0 (en) | 2003-12-24 |
WO2005049066A2 (fr) | 2005-06-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200505875A (en) | Novel compounds | |
WO2006020773A3 (fr) | Procedes permettant de preparer des plaquettes lyophilisees, compositions contenant lesdites plaquettes lyophilisees, et procedes d'utilisation associes | |
WO2007011962A3 (fr) | Traitement du cancer | |
WO2003008583A3 (fr) | Nouvelles compositions et methodes relatives au cancer | |
WO2005049593A3 (fr) | Promoteurs de l'apoptose contenant n-acylsulfonamide | |
WO2003083041A3 (fr) | Anticorps specifiques au cripto | |
WO2006133271A3 (fr) | Compositions et methodes portant sur une therapie photodynamique ciblee | |
WO2006124748A3 (fr) | Composes polycycliques et procedes pour les utiliser | |
WO2005019258A3 (fr) | Compositions et methodes de traitement de maladies relatives au systeme immunitaire | |
WO2003101397A3 (fr) | Vaccins tetravalents contre la dengue | |
ZA200409492B (en) | Compositions and methods for the diagnosis and treatment of tumor. | |
WO2006013441A3 (fr) | Utilisation de bacteries probiotiques dans la preparation de compositions topiques destinees a la protection de la peau | |
WO2004080418A3 (fr) | Composes d'acide nucleique pouvant inhiber l'angiogenese et la croissance tumorale | |
WO2004080391A3 (fr) | Nouveaux agents antibacteriens | |
WO2006128041A3 (fr) | Compositions et procedes destines a traiter ou a prevenir un neoplasme chimiomoresistant | |
WO2005118592A8 (fr) | Tetrahydropyridothiophenes utilises dans le traitement anticancereux | |
WO2003045230A3 (fr) | Compositions et procedes contre le cancer | |
EP1667685A4 (fr) | Inhibiteurs du canal potassique a base de quinazoline | |
WO2003057146A3 (fr) | Compositions et procedes concernant le cancer | |
WO2003102185A3 (fr) | Procedes et compositions pour traiter une neoplasie associee aux molecules d'acides nucleiques de a1 et a2 de hnrnp | |
WO2003053224A3 (fr) | Nouvelles compositions et methodes contre le cancer | |
WO2005077397A3 (fr) | Procedes et compositions pour le traitement de maladies vasculaires | |
GB0324656D0 (en) | A protein involved in ovarian cancer | |
WO2003087840A3 (fr) | Proteine intervenant dans le cancer | |
WO2006043060A3 (fr) | Proteine contenant le domaine mam |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
122 | Ep: pct application non-entry in european phase |